A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Clinical trial NCT00658567 · COMPLETED
Trial details
- NCT number
- NCT00658567
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-12-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.